{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:16:07Z","timestamp":1778908567967,"version":"3.51.4"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG037491"],"award-info":[{"award-number":["R01 AG037491"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01-NS120992"],"award-info":[{"award-number":["R01-NS120992"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG062677"],"award-info":[{"award-number":["P30 AG062677"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01 AG006786"],"award-info":[{"award-number":["U01 AG006786"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Transactive response DNA-binding protein 43 (TDP-43) pathology is categorized as type A-E in frontotemporal lobar degeneration and as type \u03b1-\u03b2 in Alzheimer disease (AD) based on inclusion type. We screened amygdala slides of 131 cases with varying ages at death, clinical\/neuroimaging findings, and AD neuropathologic changes for TDP-43 pathology using anti-phospho-TDP-43 antibodies. Seven cases (5%) only showed atypical TDP-43 inclusions that could not be typed. Immunohistochemistry and immunofluorescence assessed the atypical star-shaped TDP-43 pathology including its distribution, species, cellular localization, and colocalization with tau. All 7 had died at an extremely old age (median: 100\u2009years [IQR: 94\u2013101]) from nonneurological causes and none had dementia (4 cognitively unimpaired, 3 with amnestic mild cognitive impairment). Neuroimaging showed mild medial temporal involvement. Pathologically, the star-shaped TDP-43-positive inclusions were found in medial (subpial) amygdala and, occasionally, in basolateral regions. Hippocampus only showed TDP-43-positive neurites in the fimbria and subiculum while the frontal lobe was free of TDP-43 inclusions. The star-shaped inclusions were better detected with antibodies against N-terminal than C-terminal TDP-43. Double-labeling studies confirmed deposition of TDP-43 within astrocytes and colocalization with tau. We have identified a novel TDP-43 pathology with star-shaped morphology associated with superaging, with a homogeneous clinicopathologic picture, possibly representing a novel, true aging-related TDP-43 pathology.<\/jats:p>","DOI":"10.1093\/jnen\/nlad105","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T23:03:26Z","timestamp":1702422206000},"page":"36-52","source":"Crossref","is-referenced-by-count":8,"title":["Clinicopathologic features of a novel star-shaped transactive response DNA-binding protein 43 (TDP-43) pathology in the oldest old"],"prefix":"10.1093","volume":"83","author":[{"given":"Arenn F","family":"Carlos","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Sekiya","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic , Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic , Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo G","family":"Gatto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Castanedes","family":"Casey","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic , Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nha Trang Thu","family":"Pham","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Sintini","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary M","family":"Machulda","sequence":"additional","affiliation":[{"name":"Department of Psychiatry (Psychology), Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford R","family":"Jack","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val J","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L","family":"Whitwell","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic , Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Ross","family":"Reichard","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis W","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic , Jacksonville, Florida, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2930-8634","authenticated-orcid":false,"given":"Keith A","family":"Josephs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic , Rochester, Minnesota, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,12,12]]},"reference":[{"key":"2024032523550926500_nlad105-B1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","article-title":"The basis of clinicopathological heterogeneity in TDP-43 proteinopathy","volume":"138","author":"Kawakami","year":"2019","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2741\/2727","article-title":"Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease","volume":"13","author":"Buratti","year":"2008","journal-title":"Front Biosci"},{"key":"2024032523550926500_nlad105-B3","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","article-title":"TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"351","author":"Arai","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2024032523550926500_nlad105-B4","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1134108","article-title":"Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"314","author":"Neumann","year":"2006","journal-title":"Science"},{"key":"2024032523550926500_nlad105-B5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00401-013-1110-0","article-title":"TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: Correlation with argyrophilic grains but not other concomitant pathologies","volume":"126","author":"Arnold","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"key":"2024032523550926500_nlad105-B7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00401-017-1681-2","article-title":"Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: A clinico-imaging-pathological study of primary age-related tauopathy (PART)","volume":"133","author":"Josephs","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0480-1","article-title":"Phosphorylated TDP-43 in Alzheimer\u2019s disease and dementia with Lewy bodies","volume":"117","author":"Arai","year":"2009","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bpa.12424","article-title":"TDP-43 pathology in Alzheimer\u2019s disease, dementia with Lewy bodies and ageing","volume":"27","author":"McAleese","year":"2017","journal-title":"Brain Pathol"},{"key":"2024032523550926500_nlad105-B10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/mds.26809","article-title":"Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy","volume":"32","author":"Koga","year":"2017","journal-title":"Mov Disord"},{"key":"2024032523550926500_nlad105-B11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00401-010-0702-1","article-title":"Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy","volume":"120","author":"Yokota","year":"2010","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-018-1878-z","article-title":"Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: A distinct clinicopathologic subtype","volume":"136","author":"Koga","year":"2018","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3233\/JAD-221094","article-title":"Comparison of clinical, genetic, and pathologic features of limbic and diffuse transactive response DNA-binding protein 43 pathology in Alzheimer\u2019s disease neuropathologic spectrum","volume":"93","author":"Carlos","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"2024032523550926500_nlad105-B14","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/brain\/awz224","article-title":"LATE to the PART-y","volume":"142","author":"Josephs","year":"2019","journal-title":"Brain"},{"key":"2024032523550926500_nlad105-B15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/WCO.0b013e3283168d1d","article-title":"The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia","volume":"21","author":"Mackenzie","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"2024032523550926500_nlad105-B16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/01.jnen.0000248554.45456.58","article-title":"TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions","volume":"66","author":"Neumann","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523550926500_nlad105-B17","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1523\/JNEUROSCI.0248-14.2014","article-title":"Astrocytic TDP-43 pathology in Alexander disease","volume":"34","author":"Walker","year":"2014","journal-title":"J Neurosci"},{"key":"2024032523550926500_nlad105-B18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","article-title":"A harmonized classification system for FTLD-TDP pathology","volume":"122","author":"Mackenzie","year":"2011","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00401-013-1238-y","article-title":"Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD)","volume":"127","author":"Brettschneider","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40478-015-0215-1","article-title":"Incidence and extent of TDP-43 accumulation in aging human brain","volume":"3","author":"Uchino","year":"2015","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523550926500_nlad105-B21","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-009-0547-7","article-title":"Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes","volume":"118","author":"Josephs","year":"2009","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B22","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40478-014-0171-1","article-title":"TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis","volume":"2","author":"Cykowski","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523550926500_nlad105-B24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s40478-020-00934-5","article-title":"Distinct molecular patterns of TDP-43 pathology in Alzheimer\u2019s disease: Relationship with clinical phenotypes","volume":"8","author":"Tom\u00e9","year":"2020","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523550926500_nlad105-B25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s40478-019-0755-x","article-title":"C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation","volume":"7","author":"Josephs","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523550926500_nlad105-B26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","article-title":"Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis","volume":"173","author":"Igaz","year":"2008","journal-title":"Am J Pathol"},{"key":"2024032523550926500_nlad105-B27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00401-018-1951-7","article-title":"Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains","volume":"137","author":"Josephs","year":"2019","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B28","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1038\/s41467-020-19786-7","article-title":"TDP-43 interacts with amyloid-\u03b2, inhibits fibrillization, and worsens pathology in a model of Alzheimer\u2019s disease","volume":"11","author":"Shih","year":"2020","journal-title":"Nat Commun"},{"key":"2024032523550926500_nlad105-B29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/nan.12485","article-title":"TDP-43 pathology in multiple system atrophy: Colocalization of TDP-43 and \u03b1-synuclein in glial cytoplasmic inclusions","volume":"44","author":"Koga","year":"2018","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2024032523550926500_nlad105-B30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","article-title":"TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions","volume":"171","author":"Cairns","year":"2007","journal-title":"Am J Pathol"},{"key":"2024032523550926500_nlad105-B31","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00401-006-0189-y","article-title":"Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43","volume":"113","author":"Davidson","year":"2007","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","article-title":"Expansion of the classification of FTLD-TDP: Distinct pathology associated with rapidly progressive frontotemporal degeneration","volume":"134","author":"Lee","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2024032523550926500_nlad105-B34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/brain\/awz099","article-title":"Limbic-predominant age-related TDP-43 encephalopathy (LATE): Consensus working group report","volume":"142","author":"Nelson","year":"2019","journal-title":"Brain"},{"key":"2024032523550926500_nlad105-B35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00401-022-02434-3","article-title":"Frequency and distribution of TAR DNA-binding protein 43 (TDP-43) pathology increase linearly with age in a large cohort of older adults with and without dementia","volume":"144","author":"Carlos","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00401-022-02444-1","article-title":"Frequency of LATE neuropathologic change across the spectrum of Alzheimer\u2019s disease neuropathology: Combined data from 13 community-based or population-based autopsy cohorts","volume":"144","author":"Nelson","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B37","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/alz.12878","article-title":"TDP-43 pathology effect on volume and flortaucipir uptake in Alzheimer\u2019s disease","volume":"19","author":"Carlos","year":"2022","journal-title":"Alzheimers Dement"},{"key":"2024032523550926500_nlad105-B38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer\u2019s disease","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","article-title":"Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration","volume":"114","author":"Cairns","year":"2007","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2024032523550926500_nlad105-B41","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"2024032523550926500_nlad105-B42","first-page":"153","volume-title":"Recent Developments in Parkinson\u2019s Disease","author":"Fahn","year":"1987"},{"key":"2024032523550926500_nlad105-B43","volume-title":"Neuropsychological Assessment","author":"Lezak","year":"2004"},{"key":"2024032523550926500_nlad105-B44","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"2024032523550926500_nlad105-B45","volume-title":"Wechsler Adult Intelligence Scale-Revised (manual)","author":"Wechsler","year":"1981"},{"key":"2024032523550926500_nlad105-B46","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"2024032523550926500_nlad105-B47","first-page":"408","article-title":"Mayo Clinic Alzheimer\u2019s Disease Patient Registry","volume":"2","author":"Petersen","year":"1990","journal-title":"Aging (Milano)"},{"key":"2024032523550926500_nlad105-B48","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic study of aging: Design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"key":"2024032523550926500_nlad105-B49","doi-asserted-by":"crossref","first-page":"e68910","DOI":"10.1371\/journal.pone.0068910","article-title":"BrainNet viewer: A network visualization tool for human brain connectomics","volume":"8","author":"Xia","year":"2013","journal-title":"PLoS One"},{"key":"2024032523550926500_nlad105-B50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Aalzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"Braak","year":"1995","journal-title":"Neurobiol Aging"},{"key":"2024032523550926500_nlad105-B52","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"2024032523550926500_nlad105-B53","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s007020050096","article-title":"Argyrophilic grain disease: Frequency of occurrence in different age categories and neuropathological diagnostic criteria","volume":"105","author":"Braak","year":"1998","journal-title":"J Neural Transm (Vienna)"},{"key":"2024032523550926500_nlad105-B54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00401-015-1509-x","article-title":"Aging-related tau astrogliopathy (ARTAG): Harmonized evaluation strategy","volume":"131","author":"Kovacs","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B55","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"2024032523550926500_nlad105-B56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"2024032523550926500_nlad105-B57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-319-23243-0_4","volume-title":"The Amygdaloid Nuclear Complex: Anatomic Study of the Human Amygdala","author":"Di Marino","year":"2016"},{"key":"2024032523550926500_nlad105-B58","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024032523550926500_nlad105-B59","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.3389\/fphar.2019.01114","article-title":"Astrocytes: Role and functions in brain pathologies","volume":"10","author":"Siracusa","year":"2019","journal-title":"Front Pharmacol"},{"key":"2024032523550926500_nlad105-B60","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/0192623310385254","article-title":"Role of astrocytes in brain function and disease","volume":"39","author":"Sidoryk-Wegrzynowicz","year":"2011","journal-title":"Toxicol Pathol"},{"key":"2024032523550926500_nlad105-B61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuron.2013.12.034","article-title":"Reactive gliosis and the multicellular response to CNS damage and disease","volume":"81","author":"Burda Joshua","year":"2014","journal-title":"Neuron"},{"key":"2024032523550926500_nlad105-B62","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/brain\/awz419","article-title":"Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis","volume":"143","author":"Smethurst","year":"2020","journal-title":"Brain"},{"key":"2024032523550926500_nlad105-B63","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/hmg\/ddt662","article-title":"TDP-43 causes differential pathology in neuronal versus glial cells in the mouse brain","volume":"23","author":"Yan","year":"2014","journal-title":"Hum Mol Genet"},{"key":"2024032523550926500_nlad105-B64","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/neup.12038","article-title":"Accumulation of phosphorylated TDP-43 in the CNS of a patient with Cockayne syndrome","volume":"33","author":"Sakurai","year":"2013","journal-title":"Neuropathology"},{"key":"2024032523550926500_nlad105-B65","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"2024032523550926500_nlad105-B66","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-007-0331-5","article-title":"TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system","volume":"115","author":"Lee","year":"2008","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B67","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/hmg\/ddx093","article-title":"TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway","volume":"26","author":"Moujalled","year":"2017","journal-title":"Hum Mol Genet"},{"key":"2024032523550926500_nlad105-B68","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1038\/s41598-020-62864-5","article-title":"Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism","volume":"10","author":"Velebit","year":"2020","journal-title":"Sci Rep"},{"key":"2024032523550926500_nlad105-B69","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/s41467-017-01283-z","article-title":"A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models","volume":"8","author":"Tyzack","year":"2017","journal-title":"Nature Commun"},{"key":"2024032523550926500_nlad105-B70","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"2024032523550926500_nlad105-B71","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0304-3940(87)90204-7","article-title":"Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes","volume":"76","author":"Braak","year":"1987","journal-title":"Neurosci Lett"},{"key":"2024032523550926500_nlad105-B72","first-page":"278","article-title":"Clinical aspects of argyrophilic grain disease","volume":"19","author":"Ikeda","year":"2000","journal-title":"Clin Neuropathol"},{"key":"2024032523550926500_nlad105-B73","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40478-018-0552-y","article-title":"Sequential stages and distribution patterns of aging-related tau astrogliopathy (ARTAG) in the human brain","volume":"6","author":"Kovacs","year":"2018","journal-title":"Acta Neuropathol Commun"},{"key":"2024032523550926500_nlad105-B74","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0197-4580(03)00113-1","article-title":"High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe","volume":"25","author":"Schultz","year":"2004","journal-title":"Neurobiol Aging"},{"key":"2024032523550926500_nlad105-B75","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00401-007-0266-x","article-title":"Argyrophilic thorny astrocyte clusters in association with Alzheimer\u2019s disease pathology in possible primary progressive aphasia","volume":"114","author":"Munoz","year":"2007","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B76","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00401-013-1157-y","article-title":"Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: A community-based autopsy series","volume":"126","author":"Kovacs","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000341581","article-title":"Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort","volume":"34","author":"Lace","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2024032523550926500_nlad105-B78","doi-asserted-by":"crossref","DOI":"10.1111\/neup.12938","article-title":"Senile plaque-associated transactive response DNA-binding protein 43 in Alzheimer\u2019s disease: A case report spanning 16\u2009years of memory loss","author":"Carlos","year":"2023","journal-title":"Neuropathology"},{"key":"2024032523550926500_nlad105-B79","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00401-022-02416-5","article-title":"Patterns of amygdala region pathology in LATE-NC: Subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies","volume":"143","author":"Cykowski","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2024032523550926500_nlad105-B80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12987-020-00230-3","article-title":"A blood\u2013brain barrier overview on structure, function, impairment, and biomarkers of integrity","volume":"17","author":"Kadry","year":"2020","journal-title":"Fluids Barriers CNS"},{"key":"2024032523550926500_nlad105-B81","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/NEN.0b013e3181baacec","article-title":"Transactivation response DNA-binding protein 43 microvasculopathy in frontotemporal degeneration and familial Lewy body disease","volume":"68","author":"Lin","year":"2009","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Journal of Neuropathology &amp; Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/1\/36\/54770568\/nlad105.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnen\/article-pdf\/83\/1\/36\/54770568\/nlad105.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:47:22Z","timestamp":1711414042000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnen\/article\/83\/1\/36\/7471576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12,12]]},"published-print":{"date-parts":[[2023,12,22]]}},"URL":"https:\/\/doi.org\/10.1093\/jnen\/nlad105","relation":{},"ISSN":["0022-3069","1554-6578"],"issn-type":[{"value":"0022-3069","type":"print"},{"value":"1554-6578","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,1]]},"published":{"date-parts":[[2023,12,12]]}}}